Position in BIO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$322,383
New position
Shares Held
1,098
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#234
of 397 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Medical Devices
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $10,340,599 across 13 Medical Devices names. BIO ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
34,158 | $3,099,496 | |
| 2 | MDT |
Medtronic plc
|
21,126 | $1,652,686 | |
| 3 | ZBH |
Zimmer Biomet Holdings, Inc.
|
17,551 | $1,510,965 | |
| 4 | SYK |
Stryker Corp
|
3,568 | $1,123,349 | |
| 5 | BSX |
Boston Scientific Corp
|
13,995 | $597,306 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,163 | $557,504 | |
| 7 | DXCM |
Dexcom Inc
|
8,095 | $545,198 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
5,872 | $375,866 |
All Filings in BIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,383 | 1,098 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||